Related Experiment Video

Updated: Jul 16, 2026

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
13:36

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

Published on: January 21, 2010

US accelerates investment in biomedical research

D S Greenberg

    Lancet (London, England)
    |March 7, 2000
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
    06:57

    Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

    Published on: August 11, 2018

    Establishing an Octopus Ecosystem for Biomedical and Bioengineering Research
    09:10

    Establishing an Octopus Ecosystem for Biomedical and Bioengineering Research

    Published on: September 22, 2021

    Related Experiment Videos

    Last Updated: Jul 16, 2026

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
    13:36

    Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

    Published on: January 21, 2010

    Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
    06:57

    Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

    Published on: August 11, 2018

    Establishing an Octopus Ecosystem for Biomedical and Bioengineering Research
    09:10

    Establishing an Octopus Ecosystem for Biomedical and Bioengineering Research

    Published on: September 22, 2021

    Related Concept Videos

    RACE - Rapid Amplification of cDNA Ends02:35

    RACE - Rapid Amplification of cDNA Ends

    Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific primer.
    Since the...
    Preclinical Development: Overview01:28

    Preclinical Development: Overview

    Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

    Articles linked to this work by shared authors, journal, and citation graph.

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

    Lancet (London, England)·2026

    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

    Lancet (London, England)·2026

    Advancing the relevance of clinical trials for older patients.

    Lancet (London, England)·2026

    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

    Lancet (London, England)·2026

    Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

    Lancet (London, England)·2026

    Turmeric as a counterstain in histology.

    Biotechnic & histochemistry : official publication of the Biological Stain Commission·2026

    Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch.

    Frontiers in molecular neuroscience·2026

    Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction.

    Biomedical optics express·2026

    Systematic reviews of medical machine learning: limitations of pooling AUCs.

    European heart journal. Digital health·2026

    Integrating anatomical priors and clinical semantics for MRI-based diagnosis and care support in Alzheimer's disease.

    Frontiers in neuroscience·2026

    Rapid, sensitive, and highly specific diagnosis of respiratory syncytial virus using recombinase polymerase amplification-based biosensor and fluorescence detection.

    Frontiers in cellular and infection microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us